GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Clinical trial NCT07087002 · RECRUITING

Trial details

NCT number: NCT07087002
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Medulloblastoma Central Nervous System Embryonal Tumor Refractory Medulloblastoma Recurrent Medulloblastoma Pediatric Brain Tumor Embryonal Tumor With Multilayered Rosettes (ETMR)Pineoblastoma Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS CNS Neuroblastoma FOXR2-activated

Start date: 2025-08-28
Primary completion: 2027-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.